
About this episode
It’s estimated that half a million or more people around the world die of influenza each year. And many of these deaths could be prevented with a highly effective, widely used flu shot.
Now, the mRNA technology we became familiar with during the development of the Covid vaccine is being used to create a new flu shot that promises to work better than the current hit-or-miss version. It also offers the potential to bundle covid, flu, and other common viruses into a single shot.
But with vaccine skepticism running high, will people actually take it?
Bloomberg biotech reporter Angelica Peebles joins this episode to explain how the new flu shot is made, how it works, and whether it can shift how we receive and think about vaccinations.
Listen to The Big Take podcast every weekday and subscribe to our daily newsletter: https://bloom.bg/3F3EJAK
Have questions or comments for Wes and the team? Reach us at [email protected].
See omnystudio.com/listener for privacy information.
Get every episode summarized
Each time Big Take publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Big Take

So Could AI 'Kill Us All'?
Big Take

Trump Needs a Win. Enter His Venezuela Oil Deal
Big Take

Why the Bond Market Has Everyone On Edge
Big Take

Americans Are Spending Billions to Help Their Pets Live Longer
Big Take